Literature DB >> 21317614

Histochemical and immunohistochemical study in melasma: evidence of damage in the basal membrane.

Bertha Torres-Álvarez1, Iraida G Mesa-Garza, Juan P Castanedo-Cázares, Cornelia Fuentes-Ahumada, Cuauhtémoc Oros-Ovalle, Josefina Navarrete-Solis, Benjamin Moncada.   

Abstract

The pathogenesis of melasma has not been clearly elucidated. Using Fontana Masson; diastase-resistant periodic acid-Schiff stains; and immunohistochemistry to stem cell factor (SCF), its receptor c-kit, anti-mast cell tryptase, and anti-collagen type IV antibody, we evaluated melasma lesions and compared them with perilesional skin and photoprotected skin. Samples were taken from lesional and photoprotected nonlesional skin in 24 patients. In other 24 patients, we took biopsies of lesional and perilesional skin. With Fontana Masson, we observed many pigmented basal cells protruding into the dermis of the melasma skin. Periodic acid-Schiff stain and anti-collagen type IV showed damage on the basal membrane in 95.5% and 83%, respectively, in melasma lesion. The immunoreactivity of SCF and the prevalence of mast cells were increased in the dermis of melasma compared with perilesional dermis. The expression of c-kit was significantly increased at lesional epidermis; a frequent protrusion of c-kit-positive basal cells into the dermis was evident in 70% versus that in 29% of perilesional skin. The expression of c-kit was increased at lesional dermis of melasma compared with perilesional skin. We found a low correlation between c-kit expression and prevalence of mast cells; these were increased in melasma skin. The results may suggest a role of SCF, c-kit, and mast cells in the pathogenesis of melasma. We were surprised by the unexpected evidence of damage to basal membrane (BM), which could facilitate the fall or the migration of active melanocytes and melanin into the dermis allowing the constant hyperpigmentation in melasma.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21317614     DOI: 10.1097/DAD.0b013e3181ef2d45

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  23 in total

1.  In vivo multiphoton microscopy of melasma.

Authors:  Griffin Lentsch; Mihaela Balu; Joshua Williams; Sanghoon Lee; Ronald M Harris; Karsten König; Anand Ganesan; Bruce J Tromberg; Nirmala Nair; Uma Santhanam; Manoj Misra
Journal:  Pigment Cell Melanoma Res       Date:  2018-12-21       Impact factor: 4.693

2.  Melasma and laser treatment: an evidenced-based analysis.

Authors:  Shlomit Halachmi; Merete Haedersdal; Moshe Lapidoth
Journal:  Lasers Med Sci       Date:  2013-06-14       Impact factor: 3.161

3.  Sebocytes contribute to melasma onset.

Authors:  Enrica Flori; Arianna Mastrofrancesco; Sarah Mosca; Monica Ottaviani; Stefania Briganti; Giorgia Cardinali; Angela Filoni; Norma Cameli; Marco Zaccarini; Christos C Zouboulis; Mauro Picardo
Journal:  iScience       Date:  2022-02-04

4.  Cadherin 11, a miR-675 target, induces N-cadherin expression and epithelial-mesenchymal transition in melasma.

Authors:  Nan-Hyung Kim; Soo-Hyun Choi; Tae Ryong Lee; Chang-Hoon Lee; Ai-Young Lee
Journal:  J Invest Dermatol       Date:  2014-06-14       Impact factor: 8.551

Review 5.  Confetti-like Sparing: A Diagnostic Clinical Feature of Melasma.

Authors:  Douglas C Wu; Richard E Fitzpatrick; Mitchel P Goldman
Journal:  J Clin Aesthet Dermatol       Date:  2016-02

Review 6.  Participation of keratinocyte- and fibroblast-derived factors in melanocyte homeostasis, the response to UV, and pigmentary disorders.

Authors:  Parth R Upadhyay; Tina Ho; Zalfa A Abdel-Malek
Journal:  Pigment Cell Melanoma Res       Date:  2021-05-24       Impact factor: 4.693

7.  A Double-Blind, Randomized Clinical Trial of Niacinamide 4% versus Hydroquinone 4% in the Treatment of Melasma.

Authors:  Josefina Navarrete-Solís; Juan Pablo Castanedo-Cázares; Bertha Torres-Álvarez; Cuauhtemoc Oros-Ovalle; Cornelia Fuentes-Ahumada; Francisco Javier González; Juan David Martínez-Ramírez; Benjamin Moncada
Journal:  Dermatol Res Pract       Date:  2011-07-21

Review 8.  Heterogeneous Pathology of Melasma and Its Clinical Implications.

Authors:  Soon-Hyo Kwon; Young-Ji Hwang; Soo-Keun Lee; Kyoung-Chan Park
Journal:  Int J Mol Sci       Date:  2016-05-26       Impact factor: 5.923

9.  Possible Involvement of Keratinocyte Growth Factor in the Persistence of Hyperpigmentation in both Human Facial Solar Lentigines and Melasma.

Authors:  Kiyotaka Hasegawa; Rumiko Fujiwara; Kiyoshi Sato; Jaeyoung Shin; Sang Jin Kim; Misun Kim; Hee Young Kang
Journal:  Ann Dermatol       Date:  2015-10-02       Impact factor: 1.444

10.  Topical niacinamide 4% and desonide 0.05% for treatment of axillary hyperpigmentation: a randomized, double-blind, placebo-controlled study.

Authors:  Juan Pablo Castanedo-Cazares; Gabryela Lárraga-Piñones; Adriana Ehnis-Pérez; Cornelia Fuentes-Ahumada; Cuauhtemoc Oros-Ovalle; Bruce R Smoller; Bertha Torres-Álvarez
Journal:  Clin Cosmet Investig Dermatol       Date:  2013-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.